Abbott Japan, Eisai Announce Launch of Pancreatic Digestive Enzyme Replacement Drug Lipacreon

Abbott Japan and Eisai announced they will launch the pancreatic digestive enzyme replacement drug Lipacreon Capsules 150 mg and Lipacreon Granules 300 mg Sachets (pancrelipase) in Japan.
MarketWatch